Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer...

JoeTippen's profile picture

Joe Tippens

125,167 subscribers

10,621 görüntüleme • 2 ay önce •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure
3:28

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure

PharmacyinUSA

15,268 görüntüleme • 2 ay önce

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds
3:32

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 görüntüleme • 2 ay önce

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.
5:23

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.

Joe Tippens

20,297 görüntüleme • 1 ay önce

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD
4:38

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

17,944 görüntüleme • 18 gün önce

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?
3:41

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

Camus

117,774 görüntüleme • 1 yıl önce

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.
9:41

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 görüntüleme • 1 yıl önce

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD
4:13

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

skymeds store | Online Ivermectin Pharmacy

5,142,525 görüntüleme • 1 yıl önce

Studies have shown that certain electromagnetic frequencies, particularly in the low-range (100 to 300 Hz), may have the potential to disrupt cancer cell function and induce cell death, or apoptosis. Research suggests that these frequencies can interfere with cellular mechanisms by affecting ion channels and membrane potentials, disrupting cancer cells' ability to replicate and survive. One notable frequency, 100 Hz, has been explored in preclinical studies, where it was found to selectively impair cancer cells without significantly damaging healthy tissues. However, more clinical studies are required to validate the therapeutic potential of frequency-based treatments for cancer.
1:28

Studies have shown that certain electromagnetic frequencies, particularly in the low-range (100 to 300 Hz), may have the potential to disrupt cancer cell function and induce cell death, or apoptosis. Research suggests that these frequencies can interfere with cellular mechanisms by affecting ion channels and membrane potentials, disrupting cancer cells' ability to replicate and survive. One notable frequency, 100 Hz, has been explored in preclinical studies, where it was found to selectively impair cancer cells without significantly damaging healthy tissues. However, more clinical studies are required to validate the therapeutic potential of frequency-based treatments for cancer.

Barbara Oneill

114,837 görüntüleme • 1 yıl önce

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)
22:06

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 görüntüleme • 1 yıl önce

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure
3:49

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Dr. Zakaria MD

46,717 görüntüleme • 1 ay önce

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.
3:43

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 görüntüleme • 2 yıl önce

FENBENDAZOLE IS MAKING PEOPLE ASK BIGGER QUESTIONS Why are so many cancer patients suddenly talking about a dewormer? Because fenbendazole-originally used as an anti-parasitic -has shown promising early research in laboratory settings for its potential anti-cancer effects. That should make people pause. Not because it's a miracle cure. #cancer #research #fenbendazol #chemo #healing Not because it replaces treatment. But because when an overlooked compound starts showing unexpected potential... it forces a bigger question: « What else are we not paying attention to? Some studies suggest fenbendazole may interfere with how cancer cells grow and divide. And yet- most people never hear about it until they start digging for answers themselves. That's the pattern. The most interesting conversations in cancer care often happen outside the mainstream spotlight. This doesn't mean every claim is true. But it does mean this: If patients are being forced to search this hard for emerging options... the conversation is incomplete. Because people facing cancer deserve to know what research is evolving— not just what's already standardized. Stop reacting - and start making informed decisions.
2:07

FENBENDAZOLE IS MAKING PEOPLE ASK BIGGER QUESTIONS Why are so many cancer patients suddenly talking about a dewormer? Because fenbendazole-originally used as an anti-parasitic -has shown promising early research in laboratory settings for its potential anti-cancer effects. That should make people pause. Not because it's a miracle cure. #cancer #research #fenbendazol #chemo #healing Not because it replaces treatment. But because when an overlooked compound starts showing unexpected potential... it forces a bigger question: « What else are we not paying attention to? Some studies suggest fenbendazole may interfere with how cancer cells grow and divide. And yet- most people never hear about it until they start digging for answers themselves. That's the pattern. The most interesting conversations in cancer care often happen outside the mainstream spotlight. This doesn't mean every claim is true. But it does mean this: If patients are being forced to search this hard for emerging options... the conversation is incomplete. Because people facing cancer deserve to know what research is evolving— not just what's already standardized. Stop reacting - and start making informed decisions.

Joe Tippens

10,415 görüntüleme • 1 ay önce

🚨 "Ivermectin cure 28 types of Cancer" While headlines mocked ivermectin, researchers quietly tested it across 28 cancer types. The findings showed: • Slowed tumor cell growth • Targeted resistant cancer cells • Boosted chemo effectiveness Yet the public narrative stayed the same. “Don’t take it.” When a low cost, off patent drug shows potential, it raises uncomfortable questions about profit, power, and who controls the story. If you’re exploring repurposed options like Ivermectin, Fenbendazole, or Mebendazole, visit GENIX MEDS for worldwide delivery at an affordable rate without any Rx. #Ivermectin #CancerResearch #RepurposedDrugs #cancercure
12:19

🚨 "Ivermectin cure 28 types of Cancer" While headlines mocked ivermectin, researchers quietly tested it across 28 cancer types. The findings showed: • Slowed tumor cell growth • Targeted resistant cancer cells • Boosted chemo effectiveness Yet the public narrative stayed the same. “Don’t take it.” When a low cost, off patent drug shows potential, it raises uncomfortable questions about profit, power, and who controls the story. If you’re exploring repurposed options like Ivermectin, Fenbendazole, or Mebendazole, visit GENIX MEDS for worldwide delivery at an affordable rate without any Rx. #Ivermectin #CancerResearch #RepurposedDrugs #cancercure

GENIX MEDS

24,089 görüntüleme • 6 ay önce

🚨 DR WILLIAM MAKIS: “THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT” Oncologist Dr William Makis dropped a bombshell on The Shannon Joy Show — revealing what decades of cancer research have missed. “Antiparasitics have a dozen mechanisms of action… ivermectin goes after cancer stem cells… fenbendazole and mebendazole shut down glucose transporters — starving the tumor of fuel.” According to Dr Makis, chemo alone kills only the rapidly dividing cells — leaving cancer stem cells alive to spread years later. But add ivermectin, he says, and those hidden cells are targeted too — reversing resistance and triggering “tumor shrinkage oncologists have never seen.” 400+ studies now explore ivermectin’s potential role in cancer treatment — yet mainstream medicine remains silent. Could cheap, repurposed antiparasitics threaten the trillion-dollar cancer industry? Dr Makis thinks so. And he’s not backing down. Shannon Joy
3:31

🚨 DR WILLIAM MAKIS: “THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT” Oncologist Dr William Makis dropped a bombshell on The Shannon Joy Show — revealing what decades of cancer research have missed. “Antiparasitics have a dozen mechanisms of action… ivermectin goes after cancer stem cells… fenbendazole and mebendazole shut down glucose transporters — starving the tumor of fuel.” According to Dr Makis, chemo alone kills only the rapidly dividing cells — leaving cancer stem cells alive to spread years later. But add ivermectin, he says, and those hidden cells are targeted too — reversing resistance and triggering “tumor shrinkage oncologists have never seen.” 400+ studies now explore ivermectin’s potential role in cancer treatment — yet mainstream medicine remains silent. Could cheap, repurposed antiparasitics threaten the trillion-dollar cancer industry? Dr Makis thinks so. And he’s not backing down. Shannon Joy

Commentary | Global Ivermectin Research Hub

2,324,509 görüntüleme • 9 ay önce

Parasite drugs that kill cancer cells? The industry jacks up the price. Dr. Thomas Seyfried says cheap medications like Mebendazole and Fenbendazole target the same metabolic pathways in cancer cells that parasites use to survive. But once they show promise, the price skyrockets. He compared it to Martin Shkreli hiking EpiPen costs. Repurposed drugs like Mebendazole have shown anti-cancer effects in preclinical studies by disrupting microtubule function and glutamine metabolism in tumor cells, but large-scale clinical trials in humans are still limited.
1:17

Parasite drugs that kill cancer cells? The industry jacks up the price. Dr. Thomas Seyfried says cheap medications like Mebendazole and Fenbendazole target the same metabolic pathways in cancer cells that parasites use to survive. But once they show promise, the price skyrockets. He compared it to Martin Shkreli hiking EpiPen costs. Repurposed drugs like Mebendazole have shown anti-cancer effects in preclinical studies by disrupting microtubule function and glutamine metabolism in tumor cells, but large-scale clinical trials in humans are still limited.

Camus

36,269 görüntüleme • 1 ay önce

🚨 “THIS WAS NEVER SUPPOSED TO GO PUBLIC.” In a viral interview, William Makis claims cancer research missed something massive. But repurposed antiparasitics are hiding in plain sight. He says 👇 • Ivermectin targets cancer stem cells, chemo doesn’t touch • Fenbendazole and mebendazole disrupt tumor fuel pathways • Resistance may be reversed • Tumor shrinkage observed where nothing else worked Once you understand why these drugs are being studied, the next question is obvious. Where do you even get a clean, reliable supply? That’s why many independent researchers choose GENIX MEDS for ivermectin, fenbendazole, and mebendazole. Straightforward access. Affordable pricing. Worldwide delivery. #Ivermectin #Makismd #Cancercure #CancerAwareness
3:31

🚨 “THIS WAS NEVER SUPPOSED TO GO PUBLIC.” In a viral interview, William Makis claims cancer research missed something massive. But repurposed antiparasitics are hiding in plain sight. He says 👇 • Ivermectin targets cancer stem cells, chemo doesn’t touch • Fenbendazole and mebendazole disrupt tumor fuel pathways • Resistance may be reversed • Tumor shrinkage observed where nothing else worked Once you understand why these drugs are being studied, the next question is obvious. Where do you even get a clean, reliable supply? That’s why many independent researchers choose GENIX MEDS for ivermectin, fenbendazole, and mebendazole. Straightforward access. Affordable pricing. Worldwide delivery. #Ivermectin #Makismd #Cancercure #CancerAwareness

GENIX MEDS

244,061 görüntüleme • 6 ay önce

German oncologists have revealed that parasites may play a key role in the development of cancer and now research is showing that Ivermectin, a trusted anti-parasitic with decades of safe use, could also have powerful anticancer effects. This Drug could change cancer treatment.
2:20

German oncologists have revealed that parasites may play a key role in the development of cancer and now research is showing that Ivermectin, a trusted anti-parasitic with decades of safe use, could also have powerful anticancer effects. This Drug could change cancer treatment.

Amelia Brown

2,636,406 görüntüleme • 1 yıl önce

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but *NOT* the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance
6:30

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but *NOT* the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance

Jan Jekielek

96,002 görüntüleme • 1 yıl önce